Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia is a clinical trial[1].
Key Facts
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia is in the country of United Kingdom[2].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's instance of is recorded as clinical trial[3].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's start time is recorded as +2011-09-30T00:00:00Z[4].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's end time is recorded as +2015-03-31T00:00:00Z[5].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's sponsor is recorded as Imperial College London[6].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's main subject is recorded as schizophrenia[7].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's number of participants is recorded as {'unit': '1', 'amount': '+69'}[8].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's title is recorded as Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia[9].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's short name is recorded as AMICUS[10].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's ClinicalTrials.gov ID is recorded as NCT01246232[12].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[13].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's research intervention is recorded as clozapine[14].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's clinical trial phase is recorded as phase IV clinical trial[15].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's research site is recorded as University College London[16].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's research site is recorded as Imperial College London Diabetes Centre[17].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's research site is recorded as University of Manchester[18].
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia's study type is recorded as interventional study[19].